Nationwide Children’s spinoff awarded up to $14M to combat persistent pneumonia

Clarametyx licenses technology from Nationwide Children's Hospital

A Nationwide Children’s Hospital spinoff with a novel method of fighting antibiotic-resistant infections has won an up to $14.2 million grant towards commercialization.

Click here to read the complete story.

Story excerpt provided by Columbus Business First.

Written by Carrie Ghose.

Originally published November 18, 2020.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: